Case Report: Two Cases of Soft-Tissue Sarcomas: High TMB as a Potential Predictive Biomarker for Anlotinib Combined With Toripalimab Therapy

Soft-tissue sarcomas (STS), with over 100 different histologic subtypes, are rare tumors that account for 1% of all adult malignancies. Immune checkpoint inhibitors (ICIs) display certain benefits in some subtypes, especially in undifferentiated pleomorphic sarcoma (UPS), alveolar soft part sarcoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yong, Liu, Yihong, Qu, Yanchun, Chen, Xian, Qu, Xin, Ye, Yongsong, Du, Xiaohua, Cheng, Ying, Xu, Mian, Zhang, Haibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120574/
https://www.ncbi.nlm.nih.gov/pubmed/35603147
http://dx.doi.org/10.3389/fimmu.2022.832593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120574/
https://www.ncbi.nlm.nih.gov/pubmed/35603147
http://dx.doi.org/10.3389/fimmu.2022.832593

Ejemplares similares